Organisation paid for research Program year 2021 Source: CMS Open Payments

SRSD, Inc.

Neither a doctor nor a teaching hospital

Research payments

$667,826

40 payments

Through program year 2021, SRSD, Inc. is reported as receiving $667,826 in research payments, across 40 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$75,176	9
2020	Research	$592,650	31

Breakdown

Who paid Research payments · program years 2020–2021

Sunovion Pharmaceuticals Inc. $546,599 21 payments
Corcept Therapeutics $109,399 18 payments
Biogen, Inc. $11,829 1 payment

Studies the money was for Research payments · program years 2020–2021

A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia $543,562 16 payments
Cort118335-877 $84,598 10 payments
Cort118335-876 $24,800 8 payments
A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) $11,829 1 payment
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia $3,037 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.